THE USE OF URETHANE (ETHYL CARBAMATE) IN THE TREATMENT OF LEUKEMIA
Open Access
- 1 August 1948
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 3 (8) , 892-895
- https://doi.org/10.1182/blood.v3.8.892.892
Abstract
Limited experience with the use of urethane in the treatment of leukemia indicates that this substance presents a considerable promise as a palliative agent in chronic myelogenous leukemia. It has no apparent value in the treatment of acute leukemia. Further extensive observation will be necessary to provide a true measure of the clinical usefulness of this preparation.This publication has 2 references indexed in Scilit:
- Effect of Urethane on Maturation of Leukocytes of Mouse Myelogenous Leukemia.Experimental Biology and Medicine, 1947
- LEUKÆMIA TREATED WITH URETHANE COMPARED WITH DEEP X-RAY THERAPYThe Lancet, 1946